ARC Regulatory: Easing The Journey Towards Regulatory Compliance

Top 10 In Vitro Diagnostic Solution Companies in Europe - 2020

Healthcare providers rely on various tools to diagnose conditions and guide treatment decisions, with in vitro diagnostics (IVD) being one of the most commonly and widely used. IVDs are clinical tests that analyze samples taken from a patient. And as the regulatory agencies regulate these tests, manufacturers must submit studies confirming the accuracy and usefulness in diagnosing a particular condition before being launched into the market.

The future of IVD looks promising. As a whole, the preference seems to be inclining towards Point of Care (POC) diagnostics, mainly due to the advancement of technologies such as microfluidics, enabling developers to both miniaturise existing assays, but also develop new assays with a smaller footprint. Oncology is another area that is gaining traction, potentially because of the aging global population and the associated increase in the prevalence of various cancers. Personalised medicine also brings up a host of other debates – namely around data – computer learning, probabilistic algorithms, etc. are starting to generate interest, certainly from regulatory bodies. Biomarkers also seem to have the potential to play a significant role in moving forward. The market will be focusing more on handling vast amounts of patient-specific data and storing and managing that information safely.

At this juncture, there are a wide variety of solutions providers entering the industry with a set of advanced in vitro diagnostic solution offerings. To help companies navigate through the best-of-breed in vitro diagnostic solution providers, Med Tech Review has compiled a list of ‘Top 10 In Vitro Diagnostic Solution Providers in Europe – 2020.’ The enlisted organizations provide innovative IVD solutions that can detect diseases or other conditions and monitor their overall health. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CIOs.

We present to you Med Tech Review’s “Top 10 In Vitro Diagnostic Solution Providers in Europe – 2020.”

Top 10 In Vitro Diagnostic Solution Companies in Europe - 2021

    Top In Vitro Diagnostic Solution Companies in Europe

  • 3DHISTECH

    3DHISTECH

    As the first European digital pathology devices manufacturer, the company is dedicated to providing clinical pathologists, researchers, and universities with digital pathology solutions to facilitate quick and accurate diagnostics for supporting medical discoveries and fostering education. In its PANNORAMIC® Pathology Diagnostic System—an all-in-one digital pathology solution—the company has integrated different software elements to help routine pathology laboratories ensure higher throughput, lower turnaround times, and faster diagnosis. To illustrate, the system has an integrated CaseManagerTM pathology information system that provides pathologists with an easy-to-use case management function

    www.3dhistech.com

  • Devyser

    Devyser

    Devyser is a specialist in developing diagnostic kits for complex DNA testing within oncology, hereditary diseases, and transplantation

    devyser.com

  • Nexialist

    Nexialist

    A key player in medical consulting, helping its clients solve diverse compliance, quality, and regulatory-related challenges as well as build product development and commercialisation strategy

    nexialist.fr

  • Biocartis

    Biocartis

    Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Their proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases.

  • Chembio Diagnostic Systems Inc.

    Chembio Diagnostic Systems Inc.

    Chembio’s proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio’s easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.

  • digid-Digital Diagnostics

    digid-Digital Diagnostics

    Digid aims to digitise today’s diagnostics solutions through the development of a proprietary, scalable system that combines sensorics, nanotech, and AI for the first time, enabling non-invasive, real-time tracking of human biodata

  • HORIBA Medical

    HORIBA Medical

    Provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements

  • IBEXIS

    IBEXIS

    Established in 2014, IBEXI Nordic was founded to bring advanced technology and quality processes into new arenas. In response to the dramatic turn of events caused by the COVID-19 pandemic, they found that our 30 years of experience from networking, trading and introduction of advanced technology and concepts into non-technical environments could be redeployed to assist large organisations to safely connect with quality suppliers of COVID-19 related products. To ensure the best pandemic business management system and the supply of highly accurate SARS-CoV-2 rapid testing kits, IBEXIS Nordic is collaborating with Virality Diagnostics and TENTO Health. Their products are the best in the market and have CE, NHS and/or FDA and other national/regional approvals

  • Qiagen

    Qiagen

    QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Their sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).

  • Sekisui Diagnostics

    Sekisui Diagnostics

    SEKISUI Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years. They continue to invest in new diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. They are a leading provider of rapid tests in the U.S., and high throughput coagulation systems in Japan. They develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through direct sales, our commercial distribution networks and our partners.